Percutaneous tracheostomy in patients on anticoagulants.
Ann Card Anaesth
;
2015 Jul; 18(3): 329-334
Artigo
em Inglês
| IMSEAR
| ID: sea-162332
ABSTRACT
Aims:
To determine if percutaneous tracheostomy is safe in critically ill patients treated with anticoagulant therapies. Settings andDesign:
Single‑center retrospective study including all the patients who underwent percutaneous dilatational tracheostomy (PDT) placement over a 1-year period in a 14‑bed, cardiothoracic and vascular Intensive Care Unit (ICU). Materials andMethods:
Patients demographics and characteristics, anticoagulant and antiplatelet therapies, coagulation profile, performed technique and use of bronchoscopic guidance were retrieved.Results:
Thirty‑six patients (2.7% of the overall ICU population) underwent PDT over the study period. Twenty‑six (72%) patients were on anticoagulation therapy, 1 patient was on antiplatelet therapy and 2 further patients received prophylactic doses of low molecular weight heparin. Only 4 patients had normal coagulation profile and were not receiving anticoagulant or antiplatelet therapies. Overall, bleeding of any severity complicated 19% of PDT. No procedure‑related deaths occurred.Conclusions:
PDT was proved to be safe even in critically ill‑patients treated with anticoagulant therapies. Larger prospective studies are needed to confirm our findings.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Idoso de 80 Anos ou mais
/
Idoso
/
Feminino
/
Humanos
/
Inibidores da Agregação Plaquetária
/
Traqueostomia
/
Unidades de Terapia Intensiva
/
Pessoa de Meia-Idade
/
Anticoagulantes
Tipo de estudo:
Guia de Prática Clínica
/
Estudo observacional
Limite:
Aged80
Idioma:
Inglês
Revista:
Ann Card Anaesth
Ano de publicação:
2015
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS